ALPS Advisors »

Inozyme Pharma shares owned by ALPS Advisors

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $180k 42k 4.26

More positions owned by ALPS Advisors

Energy Transfer Com Ut Ltd Ptn (ET)
Western Midstream Partners L Com Unit Lp Int (WES)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Enlink Midstream Com Unit Rep Ltd (ENLC)
Nustar Energy Unit Com (NS)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Cameco Corporation (CCJ)
Genesis Energy Unit Ltd Partn (GEL)
Usa Compression Partners Comunit Ltdpar (USAC)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Global Partners Com Units (GLP)

View all positions for ALPS Advisors

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma